Loading…
ApiJect Systems America was awarded a $138 million HHS-DOD Title 3 Defense Production Act contract to accelerate building U.S.-based capacity for prefilled syringes, including Project Jumpstart to supply 100 million syringes by end of 2020 and over 500 million in 2021.